Predict your next investment

ECO Animal Health company logo
AGRICULTURE | Animal Production
ecoanimalhealth.com

See what CB Insights has to offer

About ECO Animal Health

ECO Animal Health specializes in the development and marketing of high quality medicines for the control of disease in livestock and companion animals.

ECO Animal Health Headquarter Location

PO Box 47542

London, England, N14 6WS,

United Kingdom

+44 (0)20 8 447 8899

Latest ECO Animal Health News

ECO Animal Health Group approve David Hallas’s appointment as Chief Executive Officer

Jan 18, 2022

7:12 am ECO Animal Health Group plc (LON:ECO), a leader in the development, registration and marketing of pharmaceutical products for the global animal health market, has announced that the Board of the Company has approved David Hallas’s appointment as Chief Executive Officer and a member of the Board with effect from the 1 April 2022. This follows the announcement on the 26 July 2021 regarding Marc Loomes’ intention to retire from ECO during 2022. David Hallas has over 30 years of experience in the animal health industry and is a qualified veterinarian. He is currently managing director of Sure Petcare, a wholly owned subsidiary of Merck Inc. providing digital based solutions to the companion animal sector with sales of over US$170m. Prior to this role, he was Associate Vice President of MSD Animal Health with full P&L responsibility for mid Europe which comprised a group of 7 European countries with a combined revenue of over US$450m; he has also held senior global, regional and business unit management roles in other animal health businesses within Merck, Schering Plough and Pfizer (now Zoetis) and lived and worked overseas including in the USA. David has substantial experience managing profitable growth through the introduction of new products, including vaccines, and successful merger and acquisition integrations. Marc Loomes will resign from the Board of ECO on 1 April 2022 and has agreed to support David and the Company in an advisory role for a period of time to ensure a full and thorough handover is effected. Andrew Jones, Chairman of ECO Animal Health said: “We are delighted that David has agreed to join ECO as CEO. He has considerable experience in all our major markets and product areas, and an excellent track record of managing and delivering profitable growth both in large and smaller businesses. We look forward to working with him to build shareholder value in the next exciting phase of ECO’s development. The Board also sincerely thanks Marc for his invaluable contribution to the growth and success of ECO over the last 17 years.” Good news travels fast (but only if you make that happen): Share on twitter

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.